PROCTER & GAMBLE HEALTH | AAREY DRUGS | PROCTER & GAMBLE HEALTH/ AAREY DRUGS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 40.8 | 84.9% | View Chart |
P/BV | x | 10.6 | 1.3 | 788.4% | View Chart |
Dividend Yield | % | 2.0 | 0.0 | - |
PROCTER & GAMBLE HEALTH AAREY DRUGS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
AAREY DRUGS Mar-23 |
PROCTER & GAMBLE HEALTH/ AAREY DRUGS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 51 | 10,520.8% | |
Low | Rs | 3,883 | 22 | 17,730.6% | |
Sales per share (Unadj.) | Rs | 740.7 | 165.1 | 448.7% | |
Earnings per share (Unadj.) | Rs | 138.2 | 1.5 | 9,303.6% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 2.1 | 7,367.7% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0 | - | |
Avg Dividend yield | % | 2.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 447.6 | 45.3 | 987.1% | |
Shares outstanding (eoy) | m | 16.60 | 25.38 | 65.4% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 0.2 | 2,826.6% | |
Avg P/E ratio | x | 33.5 | 24.5 | 136.3% | |
P/CF ratio (eoy) | x | 29.8 | 17.3 | 172.2% | |
Price / Book Value ratio | x | 10.3 | 0.8 | 1,285.0% | |
Dividend payout | % | 68.7 | 0 | - | |
Avg Mkt Cap | Rs m | 76,761 | 925 | 8,296.0% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 6 | 32,882.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 4,190 | 293.5% | |
Other income | Rs m | 184 | 27 | 673.9% | |
Total revenues | Rs m | 12,480 | 4,217 | 296.0% | |
Gross profit | Rs m | 3,247 | 77 | 4,205.2% | |
Depreciation | Rs m | 281 | 16 | 1,785.3% | |
Interest | Rs m | 8 | 29 | 26.9% | |
Profit before tax | Rs m | 3,142 | 60 | 5,228.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 22 | 3,784.3% | |
Profit after tax | Rs m | 2,295 | 38 | 6,085.1% | |
Gross profit margin | % | 26.4 | 1.8 | 1,432.7% | |
Effective tax rate | % | 27.0 | 37.2 | 72.4% | |
Net profit margin | % | 18.7 | 0.9 | 2,073.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 2,706 | 432.8% | |
Current liabilities | Rs m | 6,791 | 1,681 | 403.9% | |
Net working cap to sales | % | 40.0 | 24.5 | 163.7% | |
Current ratio | x | 1.7 | 1.6 | 107.2% | |
Inventory Days | Days | 263 | 6 | 4,447.4% | |
Debtors Days | Days | 343 | 1,653 | 20.8% | |
Net fixed assets | Rs m | 10,617 | 207 | 5,124.2% | |
Share capital | Rs m | 166 | 254 | 65.4% | |
"Free" reserves | Rs m | 7,265 | 897 | 809.8% | |
Net worth | Rs m | 7,431 | 1,151 | 645.6% | |
Long term debt | Rs m | 0 | 44 | 0.0% | |
Total assets | Rs m | 22,330 | 2,913 | 766.5% | |
Interest coverage | x | 409.1 | 3.1 | 13,211.1% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 0.6 | 1.4 | 38.3% | |
Return on assets | % | 10.3 | 2.3 | 452.5% | |
Return on equity | % | 30.9 | 3.3 | 942.5% | |
Return on capital | % | 42.4 | 7.4 | 570.4% | |
Exports to sales | % | 0 | 0.6 | 0.0% | |
Imports to sales | % | 13.1 | 0 | - | |
Exports (fob) | Rs m | NA | 24 | 0.0% | |
Imports (cif) | Rs m | 1,605 | NA | - | |
Fx inflow | Rs m | 1,465 | 24 | 6,192.7% | |
Fx outflow | Rs m | 1,605 | 217 | 739.7% | |
Net fx | Rs m | -140 | -193 | 72.5% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | -13 | -18,423.1% | |
From Investments | Rs m | -215 | 4 | -4,875.3% | |
From Financial Activity | Rs m | -985 | 14 | -7,272.5% | |
Net Cashflow | Rs m | 1,160 | 5 | 22,573.9% |
Indian Promoters | % | 0.0 | 45.3 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 3.4 | 587.4% | |
FIIs | % | 6.2 | 3.4 | 183.5% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 54.7 | 88.0% | |
Shareholders | 56,778 | 16,843 | 337.1% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | AAREY DRUGS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | 2.75% | 0.45% |
1-Month | -1.15% | 19.47% | 2.55% |
1-Year | 0.73% | 100.15% | 56.14% |
3-Year CAGR | -8.76% | 21.73% | 15.22% |
5-Year CAGR | 4.97% | 15.78% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the AAREY DRUGS share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of AAREY DRUGS the stake stands at 45.3%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of AAREY DRUGS.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
AAREY DRUGS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of AAREY DRUGS.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.